LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Bruker
Bruker
Bruker offers the world’s most comprehensive range of scientific instrumentation available under one brand - a brand synonymous with excellence, innovation and quality.
Tags
MALDI
LinkedIn Logo

Visualizing the Spatial Landscape of the Brain Endocannabinoidome by MALDI-2 Imaging

RECORD | Already taken place We, 20.8.2025
Explore how MALDI-2 enhances endocannabinoid imaging in brain tissue. Learn how it boosts sensitivity for neuropharmacology and brain injury research.
Go to the webinar
Bruker: Visualizing the Spatial Landscape of the Brain Endocannabinoidome by MALDI-2 Imaging
Bruker: Visualizing the Spatial Landscape of the Brain Endocannabinoidome by MALDI-2 Imaging

Endocannabinoids (eCBs) are endogenous lipid messengers that interact with cannabinoid receptors CB1/CB2 and play a critical role in the central nervous system, often altered in neurological disorders. The low concentration in tissue posts a challenge to ionize and spatially analyze these compounds. Applying a laser-induced post-ionization (MALDI-2) approach improves sensitivity and limit of detection. After optimization, this method was applied to a mouse model of mild traumatic brain injury.

Key Learning Objectives:

  • Gain an understanding of the benefits that MALDI Imaging brings to neuropharmacology applications
  • Learn applications where MALDI-2 enhances sensitivity
  • Understand the technological benefits of MALDI-2
Who should attend:
  • Researchers in pharmacology that want to add a spatial dimension to their research
  • Investigators that want to expand their technological understanding of MALDI

Presenter: Eduardo Sommella, Ph.D., Assoicate Professor, Department of Pharmacy, University of Salerno, Naples, Italy

Eduardo Sommella is Associate Professor in Medicinal Chemistry at the Department of Pharmacy of the University of Salerno (Italy), and coordinator of the Mass Spectrometry Platform. His work focuses on the development and application of multi-omics-mass spectrometry-based approaches for drug discovery and clinical-diagnostics fields.

Bruker
LinkedIn Logo
 

Related content

Overcoming Strong Solvent Effects in the Analysis of Vepdegestrant

Applications
| 2026 | Agilent Technologies
Instrumentation
HPLC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Identification of Double Bond Positions and Relative Acyl Chain Positions in Egg Yolk Phosphatidylcholines Using OAD-TOF System

Applications
| 2026 | Shimadzu
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Shimadzu
Industries
Food & Agriculture

High Molecular-Weight Polysaccharide Characterization by SEC-MALS Using GTxResolve™ 1000 and 2000 Å SEC Columns

Applications
| 2026 | Waters
Instrumentation
GPC/SEC, Consumables, LC columns
Manufacturer
Waters
Industries
Pharma & Biopharma, Food & Agriculture

Development and Optimization for a Comprehensive LC/MS/MS Method for the Detection of 74 PFAS Compounds

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Food & Agriculture

PFAS in Biota: Risk Context & Robust Analytical Solutions

Others
| 2026 | ALS Europe
Instrumentation
Laboratory analysis, LC/MS, LC/MS/MS
Manufacturer
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike